281 related articles for article (PubMed ID: 26049118)
1. Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis.
Louros NN; Tsiolaki PL; Griffin MD; Howlett GJ; Hamodrakas SJ; Iconomidou VA
Int J Biol Macromol; 2015 Aug; 79():711-8. PubMed ID: 26049118
[TBL] [Abstract][Full Text] [Related]
2. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
Wong YQ; Binger KJ; Howlett GJ; Griffin MD
FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
[TBL] [Abstract][Full Text] [Related]
3. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.
Das M; Mei X; Jayaraman S; Atkinson D; Gursky O
FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of the C-terminal truncated apolipoprotein A-I sheds new light on amyloid formation by the N-terminal fragment.
Gursky O; Mei X; Atkinson D
Biochemistry; 2012 Jan; 51(1):10-8. PubMed ID: 22229410
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel 'aggregation-prone'/'amyloidogenic determinant' peptide in the sequence of the highly amyloidogenic human calcitonin.
Iconomidou VA; Leontis A; Hoenger A; Hamodrakas SJ
FEBS Lett; 2013 Mar; 587(6):569-74. PubMed ID: 23395606
[TBL] [Abstract][Full Text] [Related]
7. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
[TBL] [Abstract][Full Text] [Related]
8. An N-terminal pro-atrial natriuretic peptide (NT-proANP) 'aggregation-prone' segment involved in isolated atrial amyloidosis.
Louros NN; Iconomidou VA; Tsiolaki PL; Chrysina ED; Baltatzis GE; Patsouris ES; Hamodrakas SJ
FEBS Lett; 2014 Jan; 588(1):52-7. PubMed ID: 24220659
[TBL] [Abstract][Full Text] [Related]
9. Structural studies and cytotoxicity assays of "aggregation-prone" IAPP(8-16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin.
Louros NN; Tsiolaki PL; Zompra AA; Pappa EV; Magafa V; Pairas G; Cordopatis P; Cheimonidou C; Trougakos IP; Iconomidou VA; Hamodrakas SJ
Biopolymers; 2015 May; 104(3):196-205. PubMed ID: 25913357
[TBL] [Abstract][Full Text] [Related]
10. Amyloid fibrils formed by selective N-, C-terminal sequences of mouse apolipoprotein A-II.
Sawashita J; Kametani F; Hasegawa K; Tsutsumi-Yasuhara S; Zhang B; Yan J; Mori M; Naiki H; Higuchi K
Biochim Biophys Acta; 2009 Oct; 1794(10):1517-29. PubMed ID: 19596087
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-I induced amyloidosis.
Genschel J; Haas R; Pröpsting MJ; Schmidt HH
FEBS Lett; 1998 Jul; 430(3):145-9. PubMed ID: 9688527
[TBL] [Abstract][Full Text] [Related]
12. C-terminal sequence of amyloid-resistant type F apolipoprotein A-II inhibits amyloid fibril formation of apolipoprotein A-II in mice.
Sawashita J; Zhang B; Hasegawa K; Mori M; Naiki H; Kametani F; Higuchi K
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E836-45. PubMed ID: 25675489
[TBL] [Abstract][Full Text] [Related]
13. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
[TBL] [Abstract][Full Text] [Related]
14. Helix-turn-helix peptides that form alpha-helical fibrils: turn sequences drive fibril structure.
Lazar KL; Miller-Auer H; Getz GS; Orgel JP; Meredith SC
Biochemistry; 2005 Sep; 44(38):12681-9. PubMed ID: 16171382
[TBL] [Abstract][Full Text] [Related]
15. The polyphenol (-)-epigallocatechin-3-gallate prevents apoA-IIowa amyloidosis in vitro and protects human embryonic kidney 293 cells against amyloid cytotoxicity.
Nakajima H; Nishitsuji K; Kawashima H; Kuwabara K; Mikawa S; Uchimura K; Akaji K; Kashiwada Y; Kobayashi N; Saito H; Sakashita N
Amyloid; 2016; 23(1):17-25. PubMed ID: 26701221
[TBL] [Abstract][Full Text] [Related]
16. The extreme N-terminal region of human apolipoprotein A-I has a strong propensity to form amyloid fibrils.
Adachi E; Kosaka A; Tsuji K; Mizuguchi C; Kawashima H; Shigenaga A; Nagao K; Akaji K; Otaka A; Saito H
FEBS Lett; 2014 Jan; 588(3):389-94. PubMed ID: 24316228
[TBL] [Abstract][Full Text] [Related]
17. Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.
Adachi E; Nakajima H; Mizuguchi C; Dhanasekaran P; Kawashima H; Nagao K; Akaji K; Lund-Katz S; Phillips MC; Saito H
J Biol Chem; 2013 Jan; 288(4):2848-56. PubMed ID: 23233678
[TBL] [Abstract][Full Text] [Related]
18. Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising α-Helical and β-Sheet Structures.
Townsend D; Hughes E; Hussain R; Siligardi G; Baldock S; Madine J; Middleton DA
Biochemistry; 2017 Mar; 56(11):1632-1644. PubMed ID: 27992182
[TBL] [Abstract][Full Text] [Related]
19. The new apolipoprotein A-I variant leu(174) --> Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide.
Obici L; Bellotti V; Mangione P; Stoppini M; Arbustini E; Verga L; Zorzoli I; Anesi E; Zanotti G; Campana C; Viganò M; Merlini G
Am J Pathol; 1999 Sep; 155(3):695-702. PubMed ID: 10487826
[TBL] [Abstract][Full Text] [Related]
20. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.
Monti DM; Guglielmi F; Monti M; Cozzolino F; Torrassa S; Relini A; Pucci P; Arciello A; Piccoli R
Eur Biophys J; 2010 Aug; 39(9):1289-99. PubMed ID: 20182709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
